ACE and heart failure: Whether myocardial damage could have been limited by early initiation of heart failure therapies such as ACE inhibitors or betablockers in those low risk patients needs further investigation, but since a recent meta-analysis among randomized controlled trials including the whole risk spectrum of patients points towards beneficial effects of these therapies [27], one may speculate that these would also help in low risk patients.